Cargando…
Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management
SIMPLE SUMMARY: Melanoma, like other solid tumors, releases DNA molecules that are referred to as circulating tumor DNA (ctDNA), into the blood and other biological fluids. ctDNA analysis performed with molecular biology techniques can provide important information on the aggressiveness of the disea...
Autores principales: | Sacco, Alessandra, Forgione, Laura, Carotenuto, Marianeve, De Luca, Antonella, Ascierto, Paolo A., Botti, Gerardo, Normanno, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601606/ https://www.ncbi.nlm.nih.gov/pubmed/33050536 http://dx.doi.org/10.3390/cancers12102914 |
Ejemplares similares
-
Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy
por: Carotenuto, Marianeve, et al.
Publicado: (2022) -
The EGFR Signaling Modulates in Mesenchymal Stem Cells the Expression of miRNAs Involved in the Interaction with Breast Cancer Cells
por: Gallo, Marianna, et al.
Publicado: (2022) -
Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics
por: Roma, Cristin, et al.
Publicado: (2022) -
Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma
por: Rachiglio, Anna Maria, et al.
Publicado: (2020) -
cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation?
por: Normanno, Nicola, et al.
Publicado: (2020)